AIDS and AIDS related infections Clinical Trials

A listing of AIDS and AIDS related infections medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 12 clinical trials
Study Evaluating Pharmacokinetics (PK) Safety and Efficacy of Cobicistat-boosted Atazanavir (ATV/co) or Cobicistat-boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in HIV-1 Infected Virologically Suppressed Pediatric Participants

Cohort 1: The primary objectives are: To evaluate the steady-state pharmacokinetics (PK) of Atazanavir (ATV) and Darunavir (DRV) and confirm the dose of Cobicistat-boosted Atazanavir (ATV/co) or Cobicistat-boosted Darunavir (DRV/co) in HIV-1 infected, virologically suppressed adolescent participants weighing 25 kg (12 to < 18 years of age) To evaluate the …

antiretroviral agents
  • 13 Jun, 2021
  • 41 locations
POC Strategies to Improve TB Care in Advanced HIV Disease

Tuberculosis (TB) remains the major cause of morbidity and mortality among patients with HIV. Sub-optimal diagnostics contributes towards poor patient outcome and there is an urgent need to identify non-sputum-based point-of-care diagnostic tests. The urine based lateral flow lipoarabinomannan TB diagnostic test (LF-LAM) is a simple, inexpensive point-of-care test. In …

HIV Vaccine
HIV Infection
night sweats
  • 11 May, 2021
  • 3 locations
Effectiveness of a Smoking Cessation Algorithm Integrated Into HIV Primary Care

To determine the efficacy of an algorithm designed to recommend smoking cessation-related pharmacotherapy options to the primary care providers of smokers living with HIV/AIDS.

nicotine patch
HIV Vaccine
nicotine replacement
smoking cessation
  • 25 Jan, 2021
  • 1 location
COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS

Patients with chronic rheumatic diseases (such as systemic lupus erythematosus [SLE], rheumatoid arthritis [RA], ankylosing spondylitis [AS], juvenile idiopathic arthritis [JIA], poly/dermatomyositis [PM/DM], systemic sclerosis [SSc], systemic vasculitis, and primary Sjgren's syndrome [pSS]) are particularly susceptible to infectious diseases due to autoimmune disorder itself and its treatment (immunosuppressive therapies). Similarly, …

HIV Vaccine
  • 21 May, 2021
  • 1 location
Treatment of PD-1 Inhibitor in AIDS-associated PML

PD-1 inhibitor Pembrolizumab, 2mg/kg weight, once per 4 weeks and 3 times of medication usagetreatment on AIDS patients with progressive multifocal leukoencephalopathy.

  • 23 Jan, 2021
  • 1 location
Technological Intervention for Reducing Alcohol Use Among People Living With HIV/AIDS

While advances in medication have led to greatly improved outcomes for people living with HIV/AIDS, less than one-third of all people living with the disease are adherent enough to their medication to achieve viral suppression. Alcohol consumption has been shown to have a significant effect on HIV medication adherence, so …

  • 27 Jan, 2021
  • 1 location
Safety and Efficacy of T8 on Treating Chronic Abnormal Immune Activation in AIDS Patients

To evaluate the efficacy and safety of taking T8 once daily on treating chronic abnormal immune activation in AIDS patients. To explore dose-effect relationships of taking T8 once dailyon treating chronic abnormal immune activation in AIDS patients.

hiv-1 rna
HIV Infection
body mass index
HIV Vaccine
  • 25 Jan, 2021
  • 4 locations
Effect of N-803 on B Cell Follicles in Antiretroviral Treated HIV Disease

N-803 has demonstrated ability to reactivate HIV from latency and can activate T cells and NK cells to clear those cells, thus reducing the reservoir. However, a concern is that CD8 T cells may be excluded from the B cell follicles, where a significant part of the reservoir resides. Webb, …

  • 01 May, 2021
  • 2 locations
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

This phase II trial studies how well donor cytotoxic T lymphocytes work in treating patients with malignancies with BK and/or JC virus. Cytotoxic T lymphocytes are made from donated blood cells that are grown in the laboratory and are designed to kill viruses that can cause infections in transplant patients …

solid tumour
solid tumors
cytotoxic chemotherapy
  • 26 Jan, 2021
  • 2 locations
SSRI Effects on Depression and Immunity in HIV/AIDS

This is a 10 week, double-blind, placebo controlled trial to evaluate SSRI (Selective Serotonin Reuptake Inhibitor) effects for treatment of depression in HIV/AIDS with a focus on innate immunity and inflammation. Depressed population is HIV + on cART (Combination Antiretroviral Therapy), not currently on pharmacotherapy for depression. Subjects will complete …

depressive disorder
behavior therapy
depressed mood
  • 24 Jan, 2021
  • 1 location